A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

Drug
Bladder health
Online since 10 November 2022, updated 516 days ago

About this trial

The purpose of this study is to evaluate the safety, efficacy, and PK of vibegron in pediatric participants with NDO who are regularly using CIC...

Included participants

Gender
All
Age
2 - 17 years
Injury level
Level not specified
  • Severity (AIS)?
  • Time since injury
    ≥ 6 months
    Healthy volunteers
    No
    Level not specified
    Additionally, participants must
    Diagnosed with Neutrogenic Detrusor Overactivity
    NO cerebral palsy, uncontrolled epilepsy, diabetes insipidus, or Stage 2 hypertension

    What’s involved

    Type

    Drug

    Details

    There are no details yet

    Potential benefits

    Main benefits

    Bladder health

    Additional benefits

    Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more

    • Trial recruitment status
    • Recruiting
    • Trial start date
    • 12 Oct 2022
    • Organisation
    • Urovant Sciences GmbH
    • Trial recruitment status
    • Recruiting
    • Trial start date
    • 12 Oct 2022
    • Organisation
    • Urovant Sciences GmbH

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more